Jade Biosciences, Inc. (JBIO)
Nasdaq: JBIO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2020
Who runs Jade Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Frohlich Tom
Chief Executive Officer. First filing May 2025, latest Feb 13, 2026, 1 filing in all.
Officers reporting now
4
of 14 people with a filing in the last fifteen months
Directors reporting now
10
35 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Frohlich Tom | Chief Executive Officer | May 2025 | Feb 13, 2026 | none |
| Dahms Bradford D. | Chief Financial Officer | Jul 2025 | Feb 13, 2026 | none |
| Balta Elizabeth | Chief Legal Officer and Corporate Secretary | May 2025 | Feb 13, 2026 | none |
| King Andrew James | Chief Scientific Officer & Head of Research and Development | May 2025 | Feb 13, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Eisner Mark | director | Jun 2026 | Jun 26, 2026 | none |
| Cain Christopher W. | director | May 2025 | Jun 11, 2026 | none |
| Dobmeier Eric | director | May 2025 | Jun 11, 2026 | none |
| Fairmount Funds Management LLC | director | May 2025 | Jun 11, 2026 | none |
| Fairmount Healthcare Co-Invest IV L.P. | director | Oct 2025 | Jun 11, 2026 | none |
| Fairmount Healthcare Fund II L.P. | director | May 2025 | Jun 11, 2026 | none |
| Harwin Peter Evan | director | May 2025 | Jun 11, 2026 | none |
| Kiselak Tomas | director | May 2025 | Jun 11, 2026 | none |
| Klein Lawrence Otto | director | May 2025 | Jun 11, 2026 | none |
| Lavelle Erin | director | May 2025 | Jun 11, 2026 | none |
Earlier names on the record31, newest filing first
Quick Jonathan · officer · last filing May 2025Kocinsky Hetal · officer · last filing May 2025Kolchinsky Peter · director · last filing Apr 2025Ra Capital Healthcare Fund LP · director · last filing Apr 2025Ra Capital Management, L.P. · director · last filing Apr 2025Shah Rajeev M. · director · last filing Apr 2025Dake Benjamin T · officer · last filing Aug 2024Ra Capital Nexus Fund, L.P. · director · last filing Jun 2024Eldridge George A · officer · last filing Jun 2024Gillies Hunter · officer · last filing Jun 2024Verwijs Marinus · officer · last filing Jun 2024Dable Habib J · director · last filing Jun 2024Dorval Allison · director · last filing Jun 2024Grayzel David S. · director · last filing Jun 2024Iwicki Mark T · director · last filing Jun 2024Katabi Maha · director · last filing Jun 2024Resnick Joshua · director · last filing Jun 2024Santel Donald J · director · last filing Jun 2024Noyes Timothy P · officer · last filing May 2024Niven Ralph · officer · last filing Feb 2024Pigot Timothy · officer · last filing Jan 2024Atlas Venture Fund Xii, L.P. · 10% owner · last filing Jul 2022Chen Bihua · 10% owner · last filing Jul 2021Cormorant Asset Management, LP · 10% owner · last filing Jul 2021Cormorant Global Healthcare Master Fund, LP · 10% owner · last filing Jul 2021Cormorant Private Healthcare Fund II, LP · 10% owner · last filing Jul 2021Atlas Venture Associates Xii, L.P. · 10% owner · last filing Jul 2021Atlas Venture Associates Xii, LLC · 10% owner · last filing Jul 2021Healy James · 10% owner · last filing Jul 2021Sofinnova Management X, L.L.C. · 10% owner · last filing Jul 2021Sofinnova Venture Partners X, L.P. · 10% owner · last filing Jul 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.